Suboxone reduces opioid cravings and blocks the effects of other opioids by partially activating the same brain receptors that drugs like heroin and oxycodone target. It contains two active ingredients: buprenorphine, which does the heavy lifting, and naloxone, which is included to discourage misuse by injection. For most people taking it as prescribed, Suboxone creates a stable, mild level of opioid receptor activity that prevents withdrawal sickness without producing a significant high.
How Suboxone Works in Your Brain
Buprenorphine, the primary ingredient, is what pharmacologists call a partial agonist at the brain’s opioid receptors. Full opioid agonists like oxycodone or heroin activate these receptors completely, producing intense euphoria and dangerous respiratory depression. Buprenorphine binds to the same receptors but only partially activates them, so the effects have a natural limit. At a daily dose of 16 mg, buprenorphine occupies roughly 90% of opioid receptors in the brain. At 32 mg, that number climbs to about 96%. But because it’s a partial agonist, more receptor coverage doesn’t translate to proportionally stronger effects.
This partial activation is what makes Suboxone useful for treating opioid dependence. It provides enough receptor stimulation to keep withdrawal at bay and reduce cravings, but not enough to produce the intense rush associated with full agonists. Buprenorphine also binds to opioid receptors with extremely high affinity and detaches slowly, meaning it can displace other opioids from those receptors and block them from taking effect. If you use heroin or a prescription opioid while on a stable Suboxone dose, you’ll feel little to nothing from it.
The Ceiling Effect on Breathing
One of Suboxone’s most important safety features is its ceiling effect on respiratory depression, which is how most opioid overdose deaths occur. In a controlled study of healthy volunteers, researchers gave two different intravenous doses of buprenorphine (one double the other) and measured breathing. Both doses slowed breathing to nearly the same degree, and the effect plateaued rather than continuing to worsen. In other words, doubling the dose increased pain relief but did not further suppress breathing. This built-in ceiling makes buprenorphine significantly safer than full opioids when taken alone, though it does not make it risk-free.
Combining Suboxone with benzodiazepines, alcohol, or other sedatives can override this safety margin. These substances suppress breathing through different pathways, and together the effects stack. Nonfatal poisoning events are more common in people taking both buprenorphine and sedatives, and the combination remains one of the leading causes of overdose among people in opioid treatment.
What Naloxone Does (and Doesn’t Do)
Naloxone is an opioid blocker included in the Suboxone formulation specifically to discourage injection misuse. When you dissolve a Suboxone tablet or film under your tongue as directed, naloxone is poorly absorbed. Most of it passes through your digestive system without reaching meaningful blood levels, so it has little pharmacological effect during normal use.
If someone dissolves Suboxone and injects it, however, the naloxone becomes fully bioavailable. In a person dependent on opioids, injected naloxone can rapidly block opioid receptors and trigger acute withdrawal, an intensely unpleasant experience. This acts as a built-in deterrent against IV misuse of the medication.
Common Side Effects During Treatment
Most people starting Suboxone notice a few predictable side effects as their body adjusts. The most frequently reported are constipation, headache, nausea, and drowsiness. Others include dizziness, sweating, dry mouth, muscle aches, blurred vision, and difficulty sleeping. These tend to be most noticeable in the first days to weeks and often improve as your body acclimates to the medication.
One less obvious effect is difficulty concentrating. Some patients report a foggy or slightly sedated feeling, particularly at higher doses, though this varies widely between individuals. Tremors, palpitations, and fever are also possible but less common.
A more serious consideration: if you take Suboxone too soon after your last dose of a full opioid, the buprenorphine can displace whatever opioid is still on your receptors and replace it with weaker activation, throwing you into what’s called precipitated withdrawal. This is why treatment guidelines require patients to abstain from opioids for at least 12 to 24 hours and be in early withdrawal before taking their first dose. Precipitated withdrawal comes on fast, feels significantly worse than regular withdrawal, and is the most commonly feared complication of starting treatment.
Dental Problems
In 2022, the FDA issued a safety warning about serious dental problems associated with buprenorphine medicines that dissolve in the mouth. The agency identified 305 reported cases of dental issues, including cavities, tooth decay, oral infections, and tooth loss, with 131 of those classified as serious. Some patients had no history of dental problems before starting treatment. The most common outcome was tooth extraction, reported in 71 cases. Others required root canals, dental surgery, crowns, or implants.
The likely mechanism involves the medication’s effect on saliva and oral pH. To reduce your risk, the FDA recommends taking a large sip of water after the medication fully dissolves, gently swishing it around your teeth and gums, then swallowing. Wait at least one hour before brushing your teeth to let your mouth chemistry normalize. Scheduling a dental visit shortly after starting Suboxone and keeping regular checkups throughout treatment is important.
Effects on the Liver
Buprenorphine can affect liver function, particularly in people with existing hepatitis B or C. Liver enzyme elevations have been reported in patients on long-term treatment, and during clinical trials, cases ranged from temporary, symptom-free bumps in liver values to rare but severe outcomes including liver failure. The risk appears to be substantially higher in people who inject buprenorphine rather than take it under the tongue. Periodic liver function monitoring is recommended for anyone on long-term treatment, especially those with preexisting liver conditions.
What Happens When You Stop
Because buprenorphine is itself an opioid (albeit a partial one), your body develops physical dependence on it over time. Stopping abruptly produces a recognizable withdrawal pattern, though one that’s generally less intense than withdrawal from full agonists like heroin or fentanyl. Buprenorphine’s long half-life means symptoms come on more slowly and stretch out over a longer period.
Physical symptoms like chills, body aches, and stomach upset typically begin within 24 hours of the last dose. These peak around 72 hours and are at their worst during that window. By the end of the first week, muscle aches, insomnia, and mood swings are common. Depression often emerges around the two-week mark. By one month, the acute physical symptoms have largely resolved, but psychological effects like depression and cravings can linger. This extended timeline is why most tapering protocols reduce the dose gradually over weeks or months rather than stopping all at once.
How It Feels Day to Day
For people stabilized on an appropriate dose, the day-to-day experience of Suboxone is relatively unremarkable, which is the point. You shouldn’t feel high, and you shouldn’t feel sick. The medication keeps opioid receptors occupied enough to prevent cravings and withdrawal while leaving you functional. Many people describe it as simply feeling “normal” for the first time in months or years.
Some people do notice mild ongoing effects: slight constipation, reduced sex drive, occasional sweating, or low-level fatigue. At lower doses (around 2 mg), only about 47% of opioid receptors are occupied, which may not be enough to fully suppress cravings in people with more severe dependence. Finding the right dose is a balancing act between controlling cravings and minimizing side effects, and it often requires adjustment in the early weeks of treatment.